Literature DB >> 16111094

Algorithm for the diagnosis and treatment of acute biliary pancreatitis.

N Alexakis1, J P Neoptolemos.   

Abstract

Gallstones are the commonest cause of acute pancreatitis in developed countries. There is now a considerable evidence base consolidated by a series of systematic reviews, meta-analyses and guidelines that has established a clear algorithm for diagnosis and management. In the majority of patients the combination of ultrasonography and serum alanine transaminase > or = 60 iu/l < or = 48 hours of symptoms will identify gallstones as the cause. The simplest method of severity assessment is a high level of serum C-reactive protein (> 150 mg/l up to 72 hours after symptoms). In mild disease, all fit patients must undergo laparoscopic cholecystectomy with intraoperative cholangiography or if not fit for surgery then endoscopic sphincterotomy during the same admission to prevent further attacks. All patients with severe disease should undergo endoscopic sphincterotomy in less than 72 hours. Patients with > 30% necrosis should undergo fine needle aspiration for bacteriology. Necrosectomy is indicated for infected necrosis or sterile necrosis if there are persisting clinically significant symptoms. There is increasing evidence for the use of minimally invasive pancreatic necrosectomy. Enteral nutrition should be instituted whenever possible but antibiotics should be reserved for patients with proven sepsis. The presence of fungal infection requires active anti-fungal therapy. Patients with severe disease should undergo cholecystectomy at a later stage. Patients who have undergone necrosectomy require long-term follow-up because of delayed complications.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16111094     DOI: 10.1177/145749690509400208

Source DB:  PubMed          Journal:  Scand J Surg        ISSN: 1457-4969            Impact factor:   2.360


  8 in total

1.  Infected pancreatic necrosis: not necessarily a late event in acute pancreatitis.

Authors:  Maxim S Petrov; Vincent Chong; John A Windsor
Journal:  World J Gastroenterol       Date:  2011-07-21       Impact factor: 5.742

2.  Resistin is not an appropriate biochemical marker to predict severity of acute pancreatitis: a case-controlled study.

Authors:  Hamdi Al-Maramhy; Abdelrahman I Abdelrahman; Samer Sawalhi
Journal:  World J Gastroenterol       Date:  2014-11-07       Impact factor: 5.742

Review 3.  Beyond acute cholecystitis-gallstone-related complications and what the emergency radiologist should know.

Authors:  Andrew Tran; Carrie Hoff; Karunesh Polireddy; Arie Neymotin; Kiran Maddu
Journal:  Emerg Radiol       Date:  2021-11-17

4.  Acute biliary pancreatitis: an experience in a tertiary level hospital of Nepal.

Authors:  Sujan Manandhar; Smith Giri; Prakash Poudel; Ramesh Singh Bhandari; Paleswan Joshi Lakhey; Pradeep Vaidya
Journal:  Indian J Surg       Date:  2012-06-08       Impact factor: 0.656

Review 5.  Minimally invasive management of pancreatic abscess, pseudocyst, and necrosis: a systematic review of current guidelines.

Authors:  Benjamin P T Loveday; Anubhav Mittal; Anthony Phillips; John A Windsor
Journal:  World J Surg       Date:  2008-11       Impact factor: 3.352

6.  Mild acute biliary pancreatitis vs cholelithiasis: are there differences in the rate of choledocholithiasis?

Authors:  Rosa Bertolín-Bernades; Luis Sabater-Ortí; Julio Calvete-Chornet; Bruno Camps-Vilata; Norberto Cassinello-Fernández; Miguel Oviedo-Bravo; Purificación Ivorra-García Monco; Raúl Cánovas-de Lucas; Salvador Lledó-Matoses
Journal:  J Gastrointest Surg       Date:  2007-07       Impact factor: 3.452

Review 7.  Acute pancreatitis: risk of recurrence and late consequences of the disease.

Authors:  Juhani Sand; Isto Nordback
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-07-07       Impact factor: 46.802

8.  Defining a therapeutic program for recurrent acute pancreatitis patients with unknown etiology.

Authors:  Vincenzo Neri; Francesco Lapolla; Alessandra Di Lascia; Libero Luca Giambavicchio
Journal:  Clin Med Insights Gastroenterol       Date:  2014-01-05
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.